Fibrogen Inc financial data

Symbol
FGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
409 Illinois Street, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 153 % -17.5%
Quick Ratio 17.5 % +3.8%
Debt-to-equity -267 % +83.1%
Return On Equity 91 % -95.3%
Return On Assets -43.6 % +23.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 100M shares +2.23%
Common Stock, Shares, Outstanding 100M shares +2.24%
Entity Public Float 262M USD -73.2%
Common Stock, Value, Issued 1M USD +2.24%
Weighted Average Number of Shares Outstanding, Basic 99.8M shares +2.16%
Weighted Average Number of Shares Outstanding, Diluted 99.8M shares +2.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 174M USD +33.1%
Cost of Revenue 40.6M USD +120%
Research and Development Expense 185M USD -39.6%
Costs and Expenses 333M USD -26.6%
Operating Income (Loss) -160M USD +50.7%
Nonoperating Income (Expense) 8.08M USD +26.1%
Income Tax Expense (Benefit) -65K USD -207%
Net Income (Loss) Attributable to Parent -168M USD +47.8%
Earnings Per Share, Basic -1.7 USD/shares +49.9%
Earnings Per Share, Diluted -1.7 USD/shares +49.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 141M USD -7.78%
Accounts Receivable, after Allowance for Credit Loss, Current 6.41M USD -75%
Inventory, Net 25.4M USD -38.3%
Other Assets, Current 3.59M USD
Assets, Current 209M USD -49.1%
Property, Plant and Equipment, Net 10.9M USD -35.1%
Operating Lease, Right-of-Use Asset 61.2M USD -17.7%
Other Assets, Noncurrent 3.05M USD -30%
Assets 293M USD -43.1%
Accounts Payable, Current 9.94M USD -22.4%
Employee-related Liabilities, Current 10.3M USD -32.4%
Accrued Liabilities, Current 114M USD -30.2%
Contract with Customer, Liability, Current 9.55M USD +27.5%
Liabilities, Current 149M USD -23.4%
Contract with Customer, Liability, Noncurrent 131M USD -20.7%
Operating Lease, Liability, Noncurrent 58.4M USD -20.9%
Other Liabilities, Noncurrent 1.01M USD -79.6%
Liabilities 484M USD -16%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.81M USD +39.1%
Retained Earnings (Accumulated Deficit) -1.89B USD -9.77%
Stockholders' Equity Attributable to Parent -232M USD -127%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -212M USD -159%
Liabilities and Equity 293M USD -43.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -59.3M USD +41.6%
Net Cash Provided by (Used in) Financing Activities -165K USD -101%
Net Cash Provided by (Used in) Investing Activities 51.3M USD -50.4%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 100M shares +2.24%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.95M USD -124%
Deferred Tax Assets, Valuation Allowance 535M USD +11.9%
Deferred Tax Assets, Gross 549M USD +11.6%
Operating Lease, Liability 73.9M USD -12.9%
Depreciation 810K USD -68.1%
Payments to Acquire Property, Plant, and Equipment 29K USD -95.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -166M USD +48.4%
Lessee, Operating Lease, Liability, to be Paid 90.3M USD -12.7%
Property, Plant and Equipment, Gross 150M USD +0.52%
Operating Lease, Liability, Current 15.5M USD +41.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.8M USD +8.87%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.6M USD +26.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.74M USD -28.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.1M USD -1.98%
Deferred Tax Assets, Operating Loss Carryforwards 175M USD +5.13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 125M shares 0%
Unrecognized Tax Benefits 81M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.5M USD +2.64%
Additional Paid in Capital 1.66B USD +2.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 14M USD -0.27%
Interest Expense 19.9M USD +199%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%